VC firms
M. H. Carnegie
Edit

M. H. Carnegie

https://www.mhcarnegie.com
Last activity: 15.08.2025
Active
Invests in categories: AdTechB2CBusinessContentMediaOnlineServiceTechnologyTimeTools
M.H. Carnegie & Co is an alternative asset manager with approximately AUD$900 million in committed funds under management across venture capital, private equity and real estate, with a successful track record since its establishment in 2010.

Our differentiated approach is a focus on building platform businesses with leaders in their industries. These leaders bring a wealth of sector knowledge and networks, which alongside our team's deep financial expertise adds substantial value to our investment platforms, creating industry leading companies and attractive returns for our investors.
News
58
Portfolio
4
Persons
12
Mentions
18

Overview

Location
Australia, New South Wales, Sydney
Employees
11-50
Founded date
2010
Investment Type
Venture Capital
Investment Stage
Series D; Private Equity

Portfolio 4

DateNameWebsiteTotal RaisedLocation
Sign up to seeSign up to seeSign up to seeSign up to seeSign up to see
RevTech Mediarevtech.mediaAustralia, New South Wales, Sydney
Strike Energystrikeenergy.com.au
Envirostream Solutions (Enviss)enviss.com.auAustralia, Victoria, Melbourne

Persons 12

DateFirst NameLast NameTitleLinkedInLocation
Sign up to seeSign up to seeSign up to seeSign up to seeSign up to seeSign up to see
TimHarrison
BenLyLinkedIn
EdwinaCobon
NatalieQuach
MichaelTraillLinkedIn
EdwardCarroll
MarkCarnegieLinkedIn
MacNelson
KateThompson
Show more

News 58

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Nov 24, 2021Silicon Valley pacemaker hopes to capture Aussie hearts with ASX floatBrisbane Times By Emma Koehn Nov 24 , 2021 Silicon Valley pacemaker startup EBR Systems expects Australia’s strong research focus on heart disease will be a fertile environment to develop the products it hopes will solve one of the world’s ...
Nov 22, 2021‘This could be as big as Cochlear’: CarnegieAustralian Financial Review By Carrie LaFrenz Nov 22 , 2021
Nov 15, 2021Cover Story: Mark Carnegie - Out with the oldFS Private Wealth By Elizabeth McArthur Nov 15, 2021 Venture capitalist Mark Carnegie was born into a wealthy and successful family and is attune to his exceptional privilege. Here he shares with Elizabeth McArthur his investing philosophy,...
Apr 27, 2021Carnegie launches crypto fundMoney Management by Mike Taylor April 27, 2021 Venture capitalist, Mark Carnegie has put a stake in the ground with respect to cryptocurrency. Carnegie has announced that his firm, MH Carnegie and Co have launched a cryptocurrency fund in p...
Mar 1, 2021Why I stopped worrying and learnt to love cryptoAustralian Financial Review by Mark Carnegie 1 March 2021 What can you do to protect against the real risk to savings when every country is printing currency as fast as the presses will go? It took too long, but I now believe that crypto is...
Feb 24, 2021NuVasive Acquires Simplify MedicalSimplify Cervical Artificial Disc provides NuVasive most clinically effective technology in the cervical total disc replacement (cTDR) procedure segment Expands growth opportunities and further differentiates Company's comprehensive portfol...
Sep 2, 2020Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral RegurgitationBy Cardiac Dimensions 2 Sep 2020 KIRKLAND, Washington, Sept. 2, 2020 /PRNewswire/ -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with he...
Apr 28, 2020Superannuation early withdrawal risks collapsing retirement systemABC News by Andrew Robertson 28 April 2020 "It was completely reasonable at the time, but it's caused a series of second-order consequences we need to think through,” says CEO and Founder Mark Carnegie. When the dust settles on the cor...
Apr 15, 2020We've mortgaged our children's future to protect health of ageing parentsSydney Morning Herald by Mark Carnegie 15 April 2020 When you spend a significant part of your life in private equity, as I have, you tend to learn a lot about what makes the industry tick. Half of that time I’ve spent working alongside the...
Show more

Mentions in press and media 18

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Mar 21, 2025Cardiac Dimensions Raises $53M in Series E FinancingCardiac Dimensions, a Kirkland, WA-based company which specializes in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), raised $53M in Series A funding. The round was led by Ally Bridge Group, with p...
May 22, 2023EBR Systems meets endpoints early in pivotal SOLVE-CRT trial: paves way for FDA approval application and commercialisationEBR Systems, Inc. (ASX: EBR), the medical device company developing wireless cardiac pacing systems, has met its primary safety and efficacy endpoints in its pivotal SOLVE-CRT trial of the WiSE® Cardiac Resynchronization Therapy (CRT) Syste...
Apr 26, 2018Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart FailureKIRKLAND, Wash.–(BUSINESS WIRE)– Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with heart failure, today announced the company has closed a $39 million Series B financing. The roun...
Nov 14, 2017Venture capitalist Mark Carnegie leads $65m wireless pacemaker fundingAustralian Financial Review by Ben Potter 14 Nov 2017 Venture capitalist Mark Carnegie was alerted years ago by a science adviser to a Californian developer of a wireless heart pacemaker that could save the lives of some patients, but he ba...
Nov 14, 2017Venture capitalist Mark Carnegie leads $65m wireless pacemaker fundingVenture capitalist Mark Carnegie was alerted years ago by a science adviser to a Californian developer of a wireless heart pacemaker that could save the lives of some patients, but he baulked at the terms.
Jul 26, 2017New nonmetal cervical disc set to reduce radiation exposure for patients after surgerySimplify enters a crowded replacement disc market. However, the company is banking that its nonmetal discs will provide a significant competitive advantage. Metal discs create artifacts that can reduce MRI image quality, forcing clinicians ...
Mar 23, 2015Australian PE shop acquires Simplify MedicalSimplify Medical said it was recently acquired by Australian private equity shop M.H. Carnegie for an undisclosed amount, as it gears up for a U.S. clinical trial of its MRI-safe artifical cervical disc. "We invested in Simplify Medica...
Nov 19, 2014Beanhunter steps into the startup crucible, Carnegie’s DenBeing thrown into Carnegie’s Den comes at the perfect time for cafe and coffee discovery startup Beanhunter, which is in the middle of a Series A funding round. The startup has been announced as a finalist for the latest Carnegie’s Den, and...
Nov 6, 2014Carnegie’s Den finalists announced as aggregations services shineComWriter, Performance Centre, Productify and Pointsbuild have been named as the four finalists for the latest Carnegie’s Den. The four startups were picked from a competitive bunch of applicants, according to MH Carnegie and Co head of new...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about M. H. Carnegie

When was M. H. Carnegie founded?

M. H. Carnegie was founded in 2010.

How many startups has M. H. Carnegie invested in?

M. H. Carnegie has 4 portfolio companies on Parsers VC, among them RevTech Media, Strike Energy and Envirostream Solutions (Enviss).

What is the latest news about M. H. Carnegie?

Parsers VC has 58 news items about M. H. Carnegie, among them “Silicon Valley pacemaker hopes to capture Aussie hearts with ASX float” (Nov 24, 2021) and “‘This could be as big as Cochlear’: Carnegie” (Nov 22, 2021).

What has the press written about M. H. Carnegie?

Parsers VC has collected 18 articles mentioning M. H. Carnegie, among them “Cardiac Dimensions Raises $53M in Series E Financing” (Mar 21, 2025) and “EBR Systems meets endpoints early in pivotal SOLVE-CRT trial: paves way for FDA approval application and commercialisation” (May 22, 2023).

Is M. H. Carnegie still active?

Yes, M. H. Carnegie is active; its latest activity on Parsers VC dates from Aug 15, 2025.